AusPAR: Lamivudine / Dolutegravir sodium / Abacavir sulfate
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
16 July 2015
| AusPAR | |
|---|---|
| Active Ingredient | Lamivudine / Dolutegravir sodium / Abacavir sulfate
|
| Product Name | Triumeq
|
| Sponsor | ViiV Healthcare Pty Ltd
|
| Submission Number | PM-2013-04112-1-2
|
| Submission Type | New fixed dose combination
|
| Decision | Approved
|
| AusPAR Date | 19 May 2015
|
| Publication Date | 16 July 2015 |